Total Payments
$11,780
2024 Payments
$1,856
Companies
31
Transactions
597
Medicare Patients
2,372
Medicare Billing
$400,860
Payment Breakdown by Category
Food & Beverage$11,719 (99.5%)
Education$61.16 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,719 | 592 | 99.5% |
| Education | $61.16 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,473 | 86 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $1,214 | 43 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $826.20 | 50 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $787.95 | 29 | $0 (2024) |
| Alkermes, Inc. | $786.81 | 43 | $0 (2024) |
| Lundbeck LLC | $775.06 | 37 | $0 (2024) |
| ITI, Inc. | $746.10 | 56 | $0 (2023) |
| Corium, LLC | $673.31 | 39 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $523.27 | 31 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $511.94 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,856 | 87 | ABBVIE INC. ($324.49) |
| 2023 | $3,227 | 166 | ABBVIE INC. ($380.59) |
| 2022 | $3,325 | 163 | ABBVIE INC. ($379.95) |
| 2021 | $3,372 | 181 | AbbVie Inc. ($387.76) |
All Payment Transactions
597 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/06/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: ADHD | ||||||
| 11/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: ADHD | ||||||
| 11/07/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $20.47 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $15.79 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $36.87 | General |
| Category: Neuropsychiatry | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/23/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $37.25 | General |
| Category: Neuroscience | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/17/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $22.37 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/15/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/15/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Neuropsychiatry | ||||||
| 10/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 552 | 1,410 | $383,438 | $100,553 |
| 2022 | 8 | 790 | 1,876 | $512,753 | $138,101 |
| 2021 | 9 | 624 | 1,347 | $354,352 | $100,720 |
| 2020 | 6 | 406 | 979 | $237,726 | $61,486 |
Total Patients
2,372
Total Services
5,612
Medicare Billing
$400,860
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 68 | 275 | $90,406 | $24,909 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 311 | $87,245 | $22,745 | 26.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 55 | 169 | $64,014 | $17,789 | 27.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 148 | 334 | $56,857 | $14,243 | 25.1% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 77 | 223 | $48,275 | $11,755 | 24.4% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 19 | 45 | $20,231 | $5,124 | 25.3% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 21 | 37 | $8,079 | $2,138 | 26.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $8,331 | $1,849 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 182 | 544 | $152,608 | $41,413 | 27.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 99 | 246 | $93,180 | $25,674 | 27.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 237 | 519 | $88,349 | $22,867 | 25.9% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 76 | 199 | $65,193 | $18,455 | 28.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 84 | 188 | $40,698 | $11,032 | 27.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 59 | 59 | $30,720 | $8,300 | 27.0% |
| 99337 | Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 16 | 58 | $28,249 | $6,885 | 24.4% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 37 | 63 | $13,756 | $3,475 | 25.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 153 | 348 | $97,624 | $27,180 | 27.8% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 218 | 575 | $97,882 | $26,416 | 27.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 126 | 191 | $72,347 | $23,124 | 32.0% |
| 99337 | Established patient assisted living visit, typically 60 minutes | Office | 2021 | 17 | 76 | $37,016 | $9,272 | 25.0% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 36 | 64 | $21,040 | $6,636 | 31.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $9,372 | $2,736 | 29.2% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 26 | 34 | $7,424 | $2,273 | 30.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 16 | 27 | $5,845 | $1,589 | 27.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $5,802 | $1,495 | 25.8% |
About Barbara Violette, APRN
Barbara Violette, APRN is a Family healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/25/2013. The National Provider Identifier (NPI) number assigned to this provider is 1174863351.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Barbara Violette, APRN has received a total of $11,780 in payments from pharmaceutical and medical device companies, with $1,856 received in 2024. These payments were reported across 597 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($11,719).
As a Medicare-enrolled provider, Violette has provided services to 2,372 Medicare beneficiaries, totaling 5,612 services with total Medicare billing of $400,860. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family, Family
- Location Fort Myers, FL
- Active Since 02/25/2013
- Last Updated 07/21/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1174863351
Products in Payments
- VRAYLAR (Drug) $1,496
- HETLIOZ (Drug) $1,186
- CAPLYTA (Drug) $835.22
- REXULTI (Drug) $792.79
- INVEGA SUSTENNA (Drug) $765.84
- ARISTADA (Drug) $718.06
- JORNAY PM (Drug) $523.27
- INGREZZA (Drug) $499.57
- LATUDA (Drug) $466.20
- BELSOMRA (Drug) $430.56
- Azstarys (Drug) $381.06
- AUSTEDO (Drug) $359.57
- ABILIFY MAINTENA (Drug) $338.99
- AZSTARYS (Drug) $244.93
- TRINTELLIX (Drug) $224.09
- NEUROSTAR TMS THERAPY SYSTEM (Device) $222.74
- BRINTELLIX (Drug) $203.57
- SUBLOCADE (Drug) $190.56
- Qelbree (Drug) $169.75
- NUEDEXTA (Drug) $147.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Fort Myers
April Stowers, Fnp-C, FNP-C
Family — Payments: $46,350
Family $46,350
Ashley Fennell, Msn, Fnp-C, MSN, FNP-C
Family — Payments: $25,988
Family $25,988
Stephanie Martinez
Family — Payments: $13,604
Family $13,604
Jenny Conrado, Arnp, ARNP
Family — Payments: $11,668
Family $11,668
Estefania Schiavi, Aprn, APRN
Family — Payments: $10,368
Family $10,368
Bindu Asok Kumar, Aprn, APRN
Family — Payments: $7,689
Family $7,689